Status:

COMPLETED

Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition

Lead Sponsor:

Dr. Reddy's Laboratories Limited

Conditions:

Healthy

Eligibility:

MALE

18-45 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to determine the pharmacokinetics and bioequivalence of isotretinoin formulations after administration of single doses to normal, non-smoking,healthy males under fasting c...

Detailed Description

An open label, randomized, single dose, oral bioequivalence study of Isotretinoin capsules 20 mg of Dr. Reddy's Laboratories Limited,under fasting conditions

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Healthy males between 18 and 45 years of age inclusive.
  • Informed of the nature of the study and given written informed consent.
  • Have a body weight within 15% of the appropriate range as defined in the 1983 Metropolitan Life Company tables and weighing at least 125 lbs. (Appendix I).
  • Exclusion Criteria
  • Hypersensitivity to isotretinoin or related compounds.
  • Any history of a clinical condition which might affect drug absorption, metabolism or excretion.
  • Recent history of mental illness, drug addiction, drug abuse or alcoholism.
  • Donation of greater than 500 ml of blood in the past 4 weeks prior to study dosing or difficulty in donating blood.
  • Received an investigational drug within the 4 weeks prior to study dosing.
  • Currently taking any prescription medication within the 7 days prior to study dosing or over-the-counter medication within 3 days of study dosing. This prohibition does not include vitamins or herbal preparations taken as nutritional supplements for non-therapeutic indications as judged by the attending physician.
  • Regular tobacco use in the 3 months prior to study dosing.

Exclusion

    Key Trial Info

    Start Date :

    August 1 2002

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2002

    Estimated Enrollment :

    41 Patients enrolled

    Trial Details

    Trial ID

    NCT01888341

    Start Date

    August 1 2002

    End Date

    August 1 2002

    Last Update

    June 27 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    AAI

    Quadrangle Drive, Chapel Hill,, North Carolina, United States, 27514